Di Giacomo AM, Chiarion-Sileni V, Del Vecchio M, Ferrucci PF, et al. Corrigendum to "Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial" [Eur J Cancer 199 (2024) 113531]. Eur J Cancer 2024 Mar 8:113981. doi: 10.1016/j.ejca.2024.113981.
PMID: 38461074